Exercise Training for Rectal Cancer Patients

Status Terminated

Clinical Trial Summary

Cancer treatments often cause acute toxicity during treatment, and late toxicity after treatments have ended. Bowel dysfunctions, incontinence (anal and urinary) and dysfunction are late side effects associated with cancer treatment in general, and patients treated for pelvic malignancies are at a higher risk. In Norway, the incidence of rectal cancer was 1329 in 2010. Advances in the treatment during the past few decades have led to fewer local recurrences and increased long-term survival, and today the relative survival is 66% for women and 64% for men. More patients are having sphincter-preserving surgery with low colorectal or ultralow coloanal anastomoses, and low anterior resection (LAR) is done in 70% of the patients with curative surgery. Unfortunately, many patients experience altered bowel function after LAR. Frequent bowel movements, urgency, evacuatory difficulties and fecal incontinence are common and distressing complications. These functional disturbances are seen in up to 50-60% of the patients, and most frequent when surgery is combined with neoadjuvant therapy. Urinary incontinence and decreased sexual function is also common in both men and women following rectal cancer treatment. In many surgical settings, patients with higher preoperative physical fitness rehabilitate more quickly and have fewer operative complications compared with patients who are less physically fit. Additionally, specific strength training of the pelvic floor muscles builds up muscle volume, elevates the location of the pelvic floor muscles and pelvic organs, and closes the levator hiatus thus providing improved structural support for the pelvic floor as well as more optimal automatic function. The aim of the present trial is to investigate whether exercise training including pelvic floor muscle training during preoperative radiotherapy can reduce symptoms of bowel, urinary and sexual dysfunction and affect the physiology of the anal sphincter muscle after LAR. In addition quality of life, cardiopulmonary parameters and postoperative complications will be studied.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Rectal Neoplasms

Clinical Trial Details

NCT number	NCT02538913
Study type	Interventional
Source	Norwegian University of Science and Technology
Contact
Status	Terminated
Phase	N/A
Start date	September 2015
Completion date	January 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02537340` - PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR
Recruiting	`NCT02565667` - A Prospective Clinical Study for Transanal Double Purse-string Rectal Anastomosis Preformed With KOL Stapler	N/A
Not yet recruiting	`NCT02439086` - Prediction of Response to Neoadjuvant Therapy in Rectal Cancer	N/A
Completed	`NCT02233374` - Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET	N/A
Completed	`NCT00535041` - Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA	N/A
Completed	`NCT00535652` - Concentration of Ertapenem in Colorectal Tissue	Phase 4
Recruiting	`NCT04949646` - Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision	N/A
Recruiting	`NCT04095468` - Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer
Recruiting	`NCT06017583` - Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer	Phase 3
Recruiting	`NCT05689775` - Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
Recruiting	`NCT04006951` - Development of a Clinical and Biological Database in Rectum Cancer	N/A
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03714490` - MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer	Phase 2
Recruiting	`NCT03325361` - The Role of Transanal Tube Drainage as A Mean of Prevention of Anastomotic Leakage Anastomotic Leakage	N/A
Completed	`NCT02252250` - Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer	N/A
Completed	`NCT04455737` - Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision
Completed	`NCT01816607` - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed	`NCT01721785` - Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer	N/A
Active, not recruiting	`NCT01171300` - Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients	N/A
Completed	`NCT01056913` - NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.